Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GB-0998 in Unexplained Recurrent Miscarriage
NCT02184741Phase 3Completed
- Sponsor
- Japan Blood Products Organization
- Start
- Jun 2014
- Primary completion
- May 2020
- Modality
- Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of polyvalent human immunoglobulin in recurrent miscarriage (RPL), sponsored by Japan Blood Products Organization. Started Jun 2014; status: completed.
02
Drugs
polyvalent human immunoglobulin
03
Conditions
recurrent miscarriage (RPL)
Beyond the preview
Go deeper on NCT02184741.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02184741.